Meeder Advisory Services Inc. lessened its holdings in shares of MetLife, Inc. (NYSE:MET – Free Report) by 7.8% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 16,097 shares of the financial services provider’s stock after selling 1,365 shares during the quarter. Meeder Advisory Services Inc.’s holdings in MetLife were worth $1,328,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also recently added to or reduced their stakes in MET. MeadowBrook Investment Advisors LLC boosted its holdings in MetLife by 244.4% in the third quarter. MeadowBrook Investment Advisors LLC now owns 310 shares of the financial services provider’s stock worth $26,000 after acquiring an additional 220 shares in the last quarter. Carmichael Hill & Associates Inc. increased its stake in MetLife by 131.9% during the 3rd quarter. Carmichael Hill & Associates Inc. now owns 327 shares of the financial services provider’s stock valued at $27,000 after purchasing an additional 186 shares in the last quarter. Wolff Wiese Magana LLC raised its holdings in shares of MetLife by 374.3% in the third quarter. Wolff Wiese Magana LLC now owns 351 shares of the financial services provider’s stock worth $29,000 after buying an additional 277 shares during the last quarter. Peterson Financial Group Inc. acquired a new stake in shares of MetLife during the third quarter worth $30,000. Finally, Fortitude Family Office LLC grew its holdings in shares of MetLife by 177.3% during the third quarter. Fortitude Family Office LLC now owns 416 shares of the financial services provider’s stock valued at $34,000 after buying an additional 266 shares during the last quarter. 89.81% of the stock is currently owned by hedge funds and other institutional investors.
MetLife Stock Up 0.0 %
Shares of MET opened at $83.37 on Tuesday. The firm has a market cap of $57.73 billion, a P/E ratio of 16.81, a PEG ratio of 0.76 and a beta of 1.05. MetLife, Inc. has a 12 month low of $61.85 and a 12 month high of $86.94. The stock’s 50 day moving average is $81.76 and its two-hundred day moving average is $75.71. The company has a current ratio of 0.16, a quick ratio of 0.16 and a debt-to-equity ratio of 0.51.
MetLife Dividend Announcement
Analyst Upgrades and Downgrades
A number of analysts have commented on the company. TD Cowen started coverage on MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 price target for the company. Morgan Stanley decreased their target price on MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a report on Monday, August 19th. Wells Fargo & Company increased their price target on shares of MetLife from $92.00 to $93.00 and gave the stock an “overweight” rating in a report on Tuesday, November 5th. Citigroup upped their price objective on shares of MetLife from $83.00 to $89.00 and gave the company a “buy” rating in a report on Tuesday, July 23rd. Finally, Jefferies Financial Group boosted their target price on shares of MetLife from $89.00 to $95.00 and gave the company a “buy” rating in a research report on Friday, September 27th. Fourteen investment analysts have rated the stock with a buy rating, According to data from MarketBeat.com, MetLife currently has an average rating of “Buy” and an average target price of $88.46.
Read Our Latest Stock Report on MetLife
MetLife Company Profile
MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.
Featured Stories
- Five stocks we like better than MetLife
- Differences Between Momentum Investing and Long Term Investing
- Is Monolithic Power Systems a Screaming Buy After Near 40% Drop?
- 3 Best Fintech Stocks for a Portfolio Boost
- Applied Materials Market Capitulates: Now is the Time to Buy
- Insider Trading – What You Need to Know
- 3 Ultra-High Dividend Yield Stocks for the New Year
Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET – Free Report).
Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.